Periconceptional use of opioids and the risk of neural tube defects

Mahsa M Yazdy1, Allen A Mitchell, Sarah C Tinker

  • 1Slone Epidemiology Center at Boston University, Boston, Massachusetts; and the National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia.

Insights

Maternal opioid use during early pregnancy is linked to a higher risk of neural tube defects in newborns. This study suggests a modest increase in birth defect prevalence associated with periconceptional opioid exposure.

Area of Science:

  • Obstetrics and Gynecology
  • Pediatric Neurology
  • Pharmacology

Background:

  • Opioid analgesics are effective for pain management but their impact on developing fetuses is not fully understood.
  • The periconceptional period is a critical window for organogenesis, making it sensitive to environmental exposures.
  • Neural tube defects (NTDs) are serious congenital anomalies with significant public health implications.

Purpose of the Study:

  • To investigate the association between maternal opioid use in the periconceptional period and the risk of neural tube defects in offspring.
  • To quantify the potential increased risk of NTDs following opioid exposure during early pregnancy.

Main Methods:

  • A case-control study utilizing data from the Slone Epidemiology Center Birth Defects Study (1998-2010).
  • Mothers of 305 infants with NTDs were compared to mothers of 7,125 non-malformed controls and 13,405 malformed controls.
  • Logistic regression models were employed to calculate adjusted odds ratios (ORs) and 95% confidence intervals (CIs) for periconceptional opioid use.

Main Results:

  • Mothers reporting opioid use in the periconceptional period had a higher incidence of NTDs compared to both non-malformed (OR 2.2) and malformed (OR 1.9) control groups.
  • The association remained significant when offspring were restricted to those with spina bifida (ORs 2.5 and 2.2, respectively).
  • Periconceptional opioid use was reported by 3.9% of mothers with NTD offspring versus 1.6% and 2.0% in control groups.

Conclusions:

  • Maternal opioid use during the periconceptional period is associated with a modest increased risk of neural tube defects.
  • This association suggests that approximately 5.9 per 10,000 live births may be attributed to NTDs among women using opioids.
  • The findings highlight the importance of considering medication safety during early pregnancy.
Abstract

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
Neurulation01:30

Neurulation

Neurulation is the embryological process which forms the precursors of the central nervous system and occurs after gastrulation has established the three primary cell layers of the embryo: ectoderm, mesoderm, and endoderm. In humans, the majority of this system is formed via primary neurulation, in which the central portion of the ectoderm—originally appearing as a flat sheet of cells—folds upwards and inwards, sealing off to form a hollow neural tube. As development proceeds, the anterior...
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
Local Anesthetics: Clinical Application as Epidural Anesthesia01:29

Local Anesthetics: Clinical Application as Epidural Anesthesia

Epidural anesthetics are administered in the fat-filled epidural space, the outermost part of the spinal canal. This technique is commonly employed for pain management and anesthesia during lower abdomen and pelvis surgeries or labor and delivery.
Since epidural anesthetics can be infused through an epidural catheter, all types of drugs, including short-acting ones, can be administered. Chloroprocaine and lidocaine are examples of short and long-duration anesthetics, respectively. Bupivacaine...